HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/4/L658    most recent 00006.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Xu, J. Articles by Rojas, M. Search for Related Content PubMed PubMed Citation Articles by Xu, J. Articles by Rojas, M.

Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet

¹Division of Pulmonary, Allergy, and Critical Care Medicine, ²Center for Translational Research in the Lung, and ³McKelvey Center for Lung Transplantation, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

Submitted 4 January 2006 ; accepted in final form 17 April 2006

The reasons for variable sensitivity among and within species to lung injury and fibrosis caused by bleomycin (BLM) are unknown. Because T helper (Th) 1 and 2 (Th1 and Th2) polarization of CD4⁺ T lymphocytes is one of the factors that affects the BLM response, we hypothesized that preventing expression of the Th1 transcription factor T-bet would render BLM-resistant BALB/c mice sensitive to BLM. Wild-type and T-bet-deficient (T-bet^–/–) BALB/c mice were treated with BLM or saline solution intratracheally. After BLM treatment, collagen content in the lung increased twofold by day 14 in lungs from T-bet^–/– mice but was unaffected in lungs from wild-type BALB/c mice. These findings were confirmed by collagen staining of histopathological sections. BLM treatment significantly increased respiratory frequency and decreased tidal volume by day 14 in T-bet^–/– mice but had no effect in wild-type mice. Lung fibrosis in BLM-treated T-bet^–/– mice was associated with increased circulating levels of Th2 cytokines and increased expression of the profibrotic factor transforming growth factor-1. Depletion of CD4⁺, but not CD8⁺, T cells in T-bet^–/– mice diminished BLM-induced lung fibrosis and the expression of transforming growth factor-1. These data suggest that the T-bet pathway in CD4⁺ T lymphocytes can confer resistance to BLM-induced lung fibrosis in BALB/c mice.

pulmonary fibrosis; Th2 response; animal models

This article has been cited by other articles:

				I. G. Luzina, N. W. Todd, A. T. Iacono, and S. P. Atamas Roles of T lymphocytes in pulmonary fibrosis J. Leukoc. Biol., February 1, 2008; 83(2): 237 - 244. [Abstract] [Full Text] [PDF]

				A. L. Mora, E. Torres-Gonzalez, M. Rojas, J. Xu, J. Ritzenthaler, S. H. Speck, J. Roman, K. Brigham, and A. Stecenko Control of Virus Reactivation Arrests Pulmonary Herpesvirus-induced Fibrosis in IFN-{gamma} Receptor-deficient Mice Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1139 - 1150. [Abstract] [Full Text] [PDF]